Home
News
Interviews
Companies
Videos
Markets
Subscribe
Recent News
Filter by Category
News
Spotlight
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filter by Company
BetterLife Pharma
w
Ketamine One
w
IntelGenx
w
Wesana Health
w
Fluence
w
The Good Shroom Co
w
Mycrodose Therapeutics
w
Seelos Therapeutics
w
Horizons ETFs Management Inc.
w
Aja Ventures
w
Algernon Pharmaceuticals
w
Creso Pharma
w
Psilotec Health Solutions
w
Silo Wellness
w
Filament Health
w
Levitee Labs
w
Bionomics
w
Mindset Pharma
w
Psyence Group
w
CB Therapeutics
w
Small Pharma
w
Bexson Biomedical
w
Diamond Therapeutics
w
PsyBio Therapeutics
w
Nova Mentis Life Science
w
Psyched Wellness
w
Pharmather
w
Optimi Health
w
MINDCURE
w
Lophora
w
Unlimited Sciences
w
Doseology Sciences
w
Magical Brands
w
Tryp Therapeutics
w
MagicMed Industries
w
Core One Labs Inc.
w
Novamind Inc.
w
GoodCap Wellness
w
Pharmadrug Inc.
w
EGF Theramed Health Corp
w
Revive Therapeutics
w
Beckley Psytech
w
Awakn Life Sciences
w
TheraPsil
w
Lobe Sciences
w
Havn Life
w
Pure Extracts Corp
w
Red Light Holland
w
Orthogonal Thinker
w
MAPS
w
Mydecine Innovations Group
w
NeonMind Biosciences Inc.
w
Molecular Science Corp.
w
Wake Network
w
Gilgamesh Pharmaceuticals
w
Eleusis
w
Entheon Biomedical
w
Octarine Bio
w
Psygen Labs
w
EI.ventures
w
Compass Pathways
w
ATAI Life Sciences
w
Mind Medicine (MindMed)
w
Field Trip Health
w
Cybin Corp
w
Braxia Scientific Corp.
w
Numinus
w
News
Algernon Pharmaceuticals Targets First Human Study of its Psychedelic Drug DMT Stroke Program for Q4, 2021
June 17, 2021
Algernon Pharmaceuticals
News
atai Life Sciences Announces Pricing of Upsized Initial Public Offering
June 17, 2021
ATAI Life Sciences
News
The Good Shroom Co Receives Authorization To Commence Sales Of The Velada Cannabis And Functional Mushroom Product Line
June 17, 2021
The Good Shroom Co
News
Braxia Scientific Awarded Government of Canada Funding to Complete First of its Kind Ketamine Clinical Trial for Bipolar Depression
June 17, 2021
Braxia Scientific Corp.
News
Ketamine One Highlights Psychedelic Research And Announces New Clinical Trial
June 17, 2021
Ketamine One
Numinus
Psyched Wellness
News
Mydecine Unveils Artificial Intelligence Drug Discovery Program
June 16, 2021
Mydecine Innovations Group
News
Core One Labs Plans Share Consolidation in Preparation of Listing its Common Shares on Nasdaq
June 16, 2021
Core One Labs Inc.
News
Cybin Selects Anxiety Disorder Indications for Proprietary Psychedelic Molecule CYB004
June 16, 2021
Cybin Corp
News
PharmaTher To Present At The H.C. Wainwright Psychedelics In Psychiatry And Beyond Virtual Conference
June 16, 2021
Pharmather
News
Creso Pharma and Red Light Holland Merge to Introduce The HighBrid Lab (TM)
June 16, 2021
Creso Pharma
News
Braxia Scientific to Present at the Psychedelics in Psychiatry and Beyond Virtual Conference Hosted by H.C. Wainwright & Co. on June 17, 2021
June 16, 2021
Braxia Scientific Corp.
News
Field Trip Health Ltd. Announces Completion of DMPK Studies, Engineering Batch for FT-104, Its Novel Psychedelic Compound
June 15, 2021
Field Trip Health
News
Novamind to Present at the H.C. Wainwright Psychedelics Conference on June 17, 2021
June 15, 2021
Novamind Inc.
News
Optimi Health Completes Pre-Clinical Trial Application Meeting
June 15, 2021
Optimi Health
News
PharmaTher Files FDA Pre-IND Meeting Request and Briefing Package For KETABET™ To Treat Depression
June 15, 2021
Pharmather
News
Ketamine One Closes Previously Announced Acquisition Of Integrated Rehab And Performance
June 15, 2021
Ketamine One
Previous
Next
